Prognostic factors in prostate cancer.
The ability of traditional and newer molecular-based prognostic factors to predict the outcome of prostate cancer is of considerable interest to urologists, pathologists, and patients. In this review, a series of traditional and newer molecular-based prognostic factors are considered, including those that have achieved widespread use, newer tests that are beginning to be used in clinical practice, and emerging molecular markers that have yet to be widely validated in the published literature or clinical trials.
Ross
Jeffrey S
JS
Department of Pathology and Laboratory Medicine, Albany Medical College, NY 12208, USA.
Jennings
Timothy A
TA
Nazeer
Tipu
T
Sheehan
Christine E
CE
Fisher
Hugh A G
HA
Kauffman
Ronald A
RA
Anwar
Shagul
S
Kallakury
Bhaskar V S
BV
D002455:Cell Division; D002869:Chromosome Aberrations; D004273:DNA, Neoplasm / Q000032:analysis; D016147:Genes, Tumor Suppressor; D006801:Humans; D008297:Male; D009367:Neoplasm Staging; D009857:Oncogenes; D011003:Ploidies; D011471:Prostatic Neoplasms / Q000098:blood supply / Q000235:genetics / Q000473:pathology*; D011944:Receptors, Androgen / Q000032:analysis
D004273:DNA, Neoplasm; D011944:Receptors, Androgen